Wednesday, December 27, 2006

The State of the Art of Treatment for Pediatric and Adolescent ADHD



Medscape News - After controlling for such differences in study design, the average effect size of nonstimulant/other medication (0.62 explored atomoxetine treatment for children aged 8 to 17 years who met criteria for both ADHD and either generalized anxiety
Source: www.medscape.com


Click here for more information about lecithin or inositol for anxiety